DK16783A - Fremgangsmaade til fremstilling af 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinoner - Google Patents

Fremgangsmaade til fremstilling af 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinoner

Info

Publication number
DK16783A
DK16783A DK16783A DK16783A DK16783A DK 16783 A DK16783 A DK 16783A DK 16783 A DK16783 A DK 16783A DK 16783 A DK16783 A DK 16783A DK 16783 A DK16783 A DK 16783A
Authority
DK
Denmark
Prior art keywords
tetrazol
quinazolinones
preparing
appropriate
benzamide
Prior art date
Application number
DK16783A
Other languages
English (en)
Other versions
DK159271C (da
DK159271B (da
DK16783D0 (da
Inventor
Norton Paul Peet
Shyam Sunder
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of DK16783D0 publication Critical patent/DK16783D0/da
Publication of DK16783A publication Critical patent/DK16783A/da
Publication of DK159271B publication Critical patent/DK159271B/da
Application granted granted Critical
Publication of DK159271C publication Critical patent/DK159271C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • C07D257/06Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Adhesive Tapes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Photolithography (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
DK016783A 1982-01-18 1983-01-17 Analogifremgangsmaade til fremstilling af 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinoner samt 2-aminobenzamider til brug som udgangsmaterialer ved fremgangsmaaden DK159271C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34057782 1982-01-18
US06/340,577 US4419357A (en) 1982-01-18 1982-01-18 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones

Publications (4)

Publication Number Publication Date
DK16783D0 DK16783D0 (da) 1983-01-17
DK16783A true DK16783A (da) 1983-07-19
DK159271B DK159271B (da) 1990-09-24
DK159271C DK159271C (da) 1991-02-18

Family

ID=23333997

Family Applications (1)

Application Number Title Priority Date Filing Date
DK016783A DK159271C (da) 1982-01-18 1983-01-17 Analogifremgangsmaade til fremstilling af 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinoner samt 2-aminobenzamider til brug som udgangsmaterialer ved fremgangsmaaden

Country Status (18)

Country Link
US (1) US4419357A (da)
EP (1) EP0086340B1 (da)
JP (1) JPS58124783A (da)
KR (1) KR880002358B1 (da)
AT (1) ATE18908T1 (da)
AU (2) AU555629B2 (da)
CA (1) CA1254204A (da)
DE (1) DE3362735D1 (da)
DK (1) DK159271C (da)
ES (1) ES519005A0 (da)
GB (2) GB2113220B (da)
GR (1) GR77393B (da)
IE (1) IE54441B1 (da)
IL (1) IL67686A (da)
NO (1) NO830115L (da)
NZ (1) NZ203034A (da)
PH (1) PH18222A (da)
ZA (1) ZA83240B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
US4644065A (en) 1984-05-15 1987-02-17 Merrell Dow Pharmaceuticals Inc. Process for the preparation of 4(3H)-quinazolinones
GB8429739D0 (en) * 1984-11-24 1985-01-03 Fbc Ltd Fungicides
US4761474A (en) * 1986-02-25 1988-08-02 Merrell Dow Pharmaceuticals Inc. 3-(1H-tetrazol-5-yl)thieno[2,3-d]pyrimidin-4(3H)-ones
US4757075A (en) * 1986-10-14 1988-07-12 Merrell Dow Pharmaceuticals Inc. Tetrazolylquinazolinones as anti-hyperuricemic agents
US8975288B2 (en) 2012-04-10 2015-03-10 The Penn State Research Foundation F2 derivatives as antibacterial agents
EP2855463B1 (en) * 2012-04-27 2018-08-01 Basf Se Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH364040A (fr) * 1960-04-19 1962-08-31 Ipa Anstalt Dispositif de détection pour vérifier si un élément d'une installation électrique est sous tension
US4035368A (en) * 1975-04-02 1977-07-12 Riker Laboratories, Inc. Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds
GB1561350A (en) * 1976-11-05 1980-02-20 May & Baker Ltd Benzamide derivatives
AU508970B2 (en) * 1976-02-13 1980-04-17 Bristol-Myers Company Tetrazole derivatives
US4122274A (en) * 1977-05-25 1978-10-24 Bristol-Myers Company 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones
US4209620A (en) * 1978-06-19 1980-06-24 Bristol-Myers Company Substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives having antiallergy activity
NZ192392A (en) * 1978-12-19 1983-02-15 M Ishikawa 3-(substituted (phenyl or pyridyl)) -3,4-dihydroquinazolin-4-ones
GB2095240A (en) * 1981-03-05 1982-09-29 Fujisawa Pharmaceutical Co Dihydropyrimidine derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones

Also Published As

Publication number Publication date
IL67686A (en) 1985-12-31
KR880002358B1 (ko) 1988-10-29
US4419357A (en) 1983-12-06
GB2170800A (en) 1986-08-13
JPH0450310B2 (da) 1992-08-13
NZ203034A (en) 1985-09-13
DK159271C (da) 1991-02-18
ATE18908T1 (de) 1986-04-15
IE54441B1 (en) 1989-10-11
NO830115L (no) 1983-07-19
GB2113220B (en) 1985-09-04
JPS58124783A (ja) 1983-07-25
KR840003250A (ko) 1984-08-20
PH18222A (en) 1985-04-30
CA1254204A (en) 1989-05-16
GB8428402D0 (en) 1984-12-19
GB8300957D0 (en) 1983-02-16
GR77393B (da) 1984-09-11
IL67686A0 (en) 1983-05-15
DK159271B (da) 1990-09-24
DK16783D0 (da) 1983-01-17
EP0086340B1 (en) 1986-04-02
ES8501758A1 (es) 1984-12-16
AU6151786A (en) 1986-12-11
IE830078L (en) 1983-07-18
ZA83240B (en) 1983-10-26
ES519005A0 (es) 1984-12-16
GB2170800B (en) 1987-01-07
EP0086340A1 (en) 1983-08-24
AU1037783A (en) 1983-07-28
DE3362735D1 (de) 1986-05-07
AU555629B2 (en) 1986-10-02
AU570852B2 (en) 1988-03-24
GB2113220A (en) 1983-08-03

Similar Documents

Publication Publication Date Title
DK84280A (da) Fremgangsmaade til formindskelse af nox-emission
DK344280A (da) Fremgangsmaade til fremstilling af aminopropoxyarylderivater
DK155944C (da) Analogifremgangsmaade til fremstilling af 7-omega-substitueretethylen(cis)-thio-acetamido)-3-cephem-4-carboxylsyrederivater.
DK16783D0 (da) Fremgangsmade til fremstilling af 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinoner
ES525256A0 (es) Procedimiento para la obtencion de 2-nitro-1,1-etendiaminas
FI841825A0 (fi) Foerbaettringar med avseende pao peresterfoereningar.
ES512324A0 (es) "procedimiento para el enfriamiento de clinker de cemento blanco".
ATE30719T1 (de) Imino-2-pyrrolidine, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
ES538576A0 (es) Procedimiento para la obtencion de derivados de arilamina
ATE23147T1 (de) Ungesaettigte verbindungen, ihre herstellung und anwendung.
DK159139C (da) Fremgangsmaade til fremstilling af flade emner, saasom luvforsynede maatter
DK159776C (da) Carbamater og oxalamider af amino-n-(1h-tetrazol-5-yl)-benzamider og fremgangsmaade til fremstilling heraf
DK149884C (da) Analogifremgangsmaade til fremstilling af lidocainsalicylat-monohydrat
JPS5227287A (en) Semiconductor laser unit
DK300183D0 (da) Fremgangsmade til fremstilling af antiallergiske pyrazin-bis-(2-oxoglycin) forbindelser
IT8319688A0 (it) Procedimento per la fabbricazione di clinker di cemento.
DK361683A (da) Fremgangsmaade til fremstilling af 5-substituerede 3-amino-isoxazoler
JPS53114011A (en) Linear motor
DK554884A (da) Fremgangsmaade til fremstilling af urinstofforbindelser
TR21972A (tr) Yeni,n-suebstituee poliglisidilurazol bilesiklerinin ueretilmesine mahsus usul
JPS5285158A (en) Hydroxynaphthoic acid anilides

Legal Events

Date Code Title Description
PBP Patent lapsed